First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Participants With Advanced Solid Tumors
Clinical trial NCT03110107 · TERMINATED
Trial details
- NCT number
- NCT03110107
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-04
- Primary completion
- 2024-04-04
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.